Full house for Fresenius as it follows up equity with loans, bonds
In a startling burst of activity that will give a measure of relief to those bankers fretting about the prospect of a slow second quarter, German healthcare company Fresenius is tapping almost all segments of the capital markets as it looks to finance its €3.1bn acquisition of Rhön-Klinikum, a hospital group.
Having raised 1.014bn through an equity capital increase earlier this month, Fresenius is now following up with plans to raise 2.697bn in the European and US loans markets, as well as some 2.089bn of high yield bonds.
Credit Suisse, Deutsche Bank, JP Morgan, Société Générale and UniCredit have underwritten
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: email@example.com or find out more online here.